Search hospitals
>
Missouri
>
Springfield
CoxHealth South Hospital
Claim this profile
Springfield, Missouri 65807
Global Leader in Breast Cancer
Global Leader in Ovarian Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
391 reported clinical trials
9 medical researchers
Summary
CoxHealth South Hospital is a medical facility located in Springfield, Missouri. This center is recognized for care of Breast Cancer, Ovarian Cancer, Lung Cancer, Cancer, Breast cancer and other specialties. CoxHealth South Hospital is involved with conducting 391 clinical trials across 534 conditions. There are 9 research doctors associated with this hospital, such as Jay W Carlson, Srikant Nannapaneni, Tania Papsdorf, MD, and Benjamin Lisle, MD.
Area of expertise
Breast Cancer
CoxHealth South Hospital has run 54 trials for Breast Cancer. Some of their research focus areas include:
Ovarian Cancer
CoxHealth South Hospital has run 47 trials for Ovarian Cancer. Some of their research focus areas include:
Top PIs
Jay W Carlson
Mercy Hospital Saint Louis
7 years of reported clinical research
Srikant Nannapaneni
Cox South Hospital
6 years of reported clinical research
Tania Papsdorf, MD
CoxHealth
4 years of reported clinical research
Benjamin Lisle, MD
Cox Medical Center South
6 years of reported clinical research
Clinical Trials running at CoxHealth South Hospital
Breast Cancer
Bladder Cancer
Lung Cancer
Breast cancer
Cancer
Prostate Cancer
Bladder Carcinoma
Ovarian Cancer
Kidney Cancer
Multiple Myeloma
Nanosomal Docetaxel
for Triple Negative Breast Cancer
This trial tests a new, safer form of the cancer drug docetaxel, called Nanosomal Docetaxel Lipid Suspension (NDLS), in patients with advanced or spreading triple-negative breast cancer. NDLS aims to reduce side effects by using tiny fat particles. The drug works by stopping cancer cells from dividing and growing. Docetaxel is a widely used chemotherapy drug, and newer formulations like Nanosomal Docetaxel Lipid Suspension (NDLS) aim to improve its efficacy and reduce toxicity.
Recruiting
4 awards
Phase 3
13 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting
2 awards
Phase 3
23 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting
2 awards
Phase 3
47 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CoxHealth South Hospital?
CoxHealth South Hospital is a medical facility located in Springfield, Missouri. This center is recognized for care of Breast Cancer, Ovarian Cancer, Lung Cancer, Cancer, Breast cancer and other specialties. CoxHealth South Hospital is involved with conducting 391 clinical trials across 534 conditions. There are 9 research doctors associated with this hospital, such as Jay W Carlson, Srikant Nannapaneni, Tania Papsdorf, MD, and Benjamin Lisle, MD.
Where is CoxHealth South Hospital located?
CoxHealth South Hospital is located at 3801 S. National Ave., Springfield, MO 65807.
Who should I call to ask about financial aid or insurance network?
For financial assistance at CoxHealth South Hospital, please call a financial counselor at 417-269-3117. For insurance-related inquiries, insured individuals should contact their provider, while uninsured individuals should refer to Schedule 6. For general inquiries, contact CoxHealth at 417-269-3000.
What insurance does CoxHealth South Hospital accept?
CoxHealth South Hospital accepts a wide range of insurance plans, such as Humana Commercial Products, Humana Medicare Advantage, Healthy Blue Missouri (Managed Medicaid), MedRisk, LLC, UnitedHealthcare, Aetna, Anthem, Blue Cross Blue Shield, Cigna, Mid America Health, and One Health Plan. Always verify with the hospital or your insurance provider to confirm coverage.
What awards or recognition has CoxHealth South Hospital received?
CoxHealth South Hospital, located in Springfield, Missouri, is a Certified Treatment Center of Excellence for its ALS Clinic, as recognized by The ALS Association. Furthermore, CoxHealth's Springfield hospitals, including Cox Medical Center South, have achieved Magnet recognition, signifying excellence in nursing and high-quality patient care.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.